Literature DB >> 18187153

Functional intracellular antibody fragments do not require invariant intra-domain disulfide bonds.

Tomoyuki Tanaka1, Terence H Rabbitts.   

Abstract

Intracellular antibody fragments that interfere with molecular interactions inside cells are valuable in investigation of interactomes and in therapeutics, but their application demands that they function in the reducing cellular milieu. We show here a 2.7-A crystal structure of intracellular antibody folds based on scaffolds developed from intracellular antibody capture technology, and we reveal that there is no structural or functional difference with or without the intra-domain disulfide bond of the variable domain of heavy chain or the variable domain of light chain. The data indicate that, in the reducing in vivo environment, the absence of the intra-domain disulfide bond is not an impediment to correction of antibody folding or to interaction with antigen. Thus, the structural constraints for in-cell function are intrinsic to variable single-domain framework sequences, providing a generic scaffold for isolation of functional intracellular antibody single domains.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18187153     DOI: 10.1016/j.jmb.2007.11.085

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

Review 1.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

2.  Protocol for the selection of single-domain antibody fragments by third generation intracellular antibody capture.

Authors:  Tomoyuki Tanaka; Terence H Rabbitts
Journal:  Nat Protoc       Date:  2009-12-17       Impact factor: 13.491

3.  Delivery of antibodies to the cytosol: debunking the myths.

Authors:  Andrea L J Marschall; Congcong Zhang; André Frenzel; Thomas Schirrmann; Michael Hust; Franck Perez; Stefan Dübel
Journal:  MAbs       Date:  2014-05-21       Impact factor: 5.857

4.  Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifs.

Authors:  Andrew S Dixon; Jonathan E Constance; Tomoyuki Tanaka; Terence H Rabbitts; Carol S Lim
Journal:  Pharm Res       Date:  2011-12-20       Impact factor: 4.200

5.  Engineering antibody fragments to fold in the absence of disulfide bonds.

Authors:  Min Jeong Seo; Ki Jun Jeong; Clinton E Leysath; Andrew D Ellington; Brent L Iverson; George Georgiou
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

6.  Single domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domain.

Authors:  Tomoyuki Tanaka; Helen Sewell; Simon Waters; Simon E V Phillips; Terence H Rabbitts
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

Review 7.  Therapeutic Antibodies against Intracellular Tumor Antigens.

Authors:  Iva Trenevska; Demin Li; Alison H Banham
Journal:  Front Immunol       Date:  2017-08-18       Impact factor: 7.561

Review 8.  Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology.

Authors:  Congcong Zhang; Rina M Ötjengerdes; Julian Roewe; Rebeca Mejias; Andrea L J Marschall
Journal:  BioDrugs       Date:  2020-08       Impact factor: 5.807

9.  Single domain intrabodies against WASP inhibit TCR-induced immune responses in transgenic mice T cells.

Authors:  Mitsuru Sato; Ryoko Sawahata; Chisato Sakuma; Takato Takenouchi; Hiroshi Kitani
Journal:  Sci Rep       Date:  2013-10-21       Impact factor: 4.379

10.  Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds.

Authors:  Abimael Cruz-Migoni; Peter Canning; Camilo E Quevedo; Carole J R Bataille; Nicolas Bery; Ami Miller; Angela J Russell; Simon E V Phillips; Stephen B Carr; Terence H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.